Technical / White Paper
From the Loading Dock to Quality Stock: Three Scenarios to Reduce Incoming Inspection Costs
This whitepaper describes three scenarios that clearly demonstrate the value TruScan brings to pharmaceutical manufacturing facilities and the underlying benefits of implementing TruScan that make such extensive savings possible.
Each case study provides an in-depth examination of the deployments of TruScan and concludes with a detailed assessment of the financial yield, from payback through ongoing cost-benefit analysis.
The facilities in all three cases were able to implement TruScan and then recover the initial investment and startup costs quickly—all broke even within 12 months. Projected four-year returns on investment ranged from 268% to 339%, and cost savings ranged from ~US$600,000 to >$800,000.